top of page

GPCR News

Post: Blog2_Post

Search

Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team

GPCR News
Nov 1, 2021
1 min read

November 2021

"November 11, 2021 7:00am EST

Patricia Drake appointed new Chief Commercial Officer

CHESTERBROOK, Pa., Nov. 11, 2021 -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the addition of Patricia Drake to its senior leadership team as Chief Commercial Officer." Read more at the source

#DrGPCR #GPCR #IndustryNews

Recent Posts

Emerging approaches for decoding neuropeptide transmission

November 2022 "Neuropeptides produce robust effects on behavior across species, and recent research has benefited from advances in...

Location bias contributes to functionally selective responses of biased CXCR3 agonists

November 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially activate specific signaling...

Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...

November 2022 Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell cycle and metastasis...

Comments

bottom of page